Combined oral low-dose cyclophosphamide endocrine therapy may improve clinical response among patients with metastatic breast cancer via Tregs in TLSsYuze Zhao, Huixia Zheng, Dongwen Rong et al.|Scientific Reports|2024Cited by 8
Clofazimine enhances anti-PD-1 immunotherapy in glioblastoma by inhibiting Wnt6 signaling and modulating the tumor immune microenvironmentYuze Zhao, Shuo Wang, Yuguang Song et al.|Cancer Immunology Immunotherapy|2025Cited by 3
Oral low-dose cyclophosphamide with endocrine therapy through effects on Tregs in TLSs may improve clinical response in elderly metastatic breast cancer patientsYuze Zhao, Huixia Zheng, Hongyan Huang et al.|Research Square|2023Cited by 0